Thyroid disorders from hormone source to treatment
Interpret thyroid tests, distinguish hormone synthesis from leakage, choose treatment, and recognize thyroid emergencies, pregnancy changes, and nodules.
In a patient with elevated free thyroid hormones, suppressed TSH fits the expected negative-feedback response. It does not tell you whether the thyroid is making new hormone, releasing stored hormone, or responding to medication. That distinction decides whether an antithyroid drug can help.
Name the biochemical state first. Find the hormone source second. Treat the source while checking for organ failure.
Read TSH beside free T4
The hypothalamus releases TRH, the anterior pituitary releases TSH, and follicular cells produce mostly T4 plus some T3. Peripheral tissues convert T4 to the more active T3. Feedback usually suppresses TSH when circulating hormone rises. This relationship assumes the hypothalamus and pituitary work normally. A normal TSH is not reassuring when free T4 is low and pituitary disease is plausible. [1]
Four laboratory patterns
High TSH with low free T4
Overt primary hypothyroidism. The thyroid cannot meet the pituitary signal.
Low TSH with high free T4 or T3
Thyrotoxicosis. Determine whether hormone synthesis is increased.
Abnormal TSH with normal free hormones
Subclinical dysfunction after transient illness, assay effects, and drugs are considered. Symptoms may still occur.
Low free T4 with low, normal, or mildly high TSH
Possible central hypothyroidism. The TSH concentration can conceal weak biological activity. Assess other pituitary hormones, especially cortisol.
When TSH is suppressed but free T4 is normal, measure T3 before calling the condition subclinical. T3-predominant Graves disease or an autonomous nodule can already cause overt thyrotoxicosis. Conversely, T3 may remain normal in primary hypothyroidism and is not the main diagnostic or replacement target. High free hormones with nonsuppressed TSH require confirmation for interference before investigating thyroid-hormone resistance or a TSH-secreting pituitary tumor. [1]
Use physiology to organize the examination
Hormone excess increases thermogenesis and adrenergic responsiveness. Look for heat intolerance, weight loss despite appetite, sweating, fine tremor, brisk reflexes, frequent stools, tachycardia, atrial fibrillation, and widened pulse pressure. Older adults may instead show apathy or unexplained atrial fibrillation. Hormone deficiency produces cold intolerance, constipation, fatigue, modest weight gain, dry coarse skin, bradycardia, and delayed relaxation of deep tendon reflexes. Menstrual disturbance and impaired fertility can occur in either state. Hypothyroidism can accompany high LDL, increased CK, hyponatremia, and pericardial effusion; associated anemia has several possible causes. These findings support testing but do not replace it. [2][3]
Try it here · Checkpoint 1 of 3
Make your prediction before reading the choices. A first attempt is just a starting point.
Case 2
Show answer and explanations for case 2
A. Sheets of calcitonin-positive cells with amyloid (Why this does not fit)
That indicates medullary carcinoma, not the expected autoimmune background.
B. Undifferentiated malignant giant cells (Why this does not fit)
These favor anaplastic carcinoma and do not explain the described chronic autoimmune pattern.
C. Lymphoid germinal centers with Hürthle-cell change (Best answer)
This inflammatory and oncocytic pattern supports Hashimoto in the setting of overt primary hypothyroidism.
D. Capsular invasion by a follicular neoplasm (Why this does not fit)
Capsular invasion defines malignancy in a follicular tumor, not Hashimoto thyroiditis.
Takeaway: Hashimoto is immune-mediated follicular injury, not simply a positive antibody test.
Three routes to thyrotoxicosis. Read each route from source to test to treatment.
New synthesis
Graves or autonomous nodules → active iodine handling → thionamide or definitive thyroid therapy.
Stored hormone leakage
Inflamed follicles → low uptake during the thyrotoxic phase → symptom and inflammation treatment.
Hormone taken by mouth
Exogenous T4 or T3 → suppressed gland and often low thyroglobulin → review and adjust the exposure.
Recent iodine exposure can lower uptake even when synthesis is increased. Pregnancy changes which tests are permissible. [4][5]
Graves disease is driven by stimulating TSH-receptor antibodies. TRAb describes receptor-binding antibodies that can stimulate, block, or have neutral activity; TSI assays assess stimulating activity. Anti-TPO supports thyroid autoimmunity but does not uniquely identify Graves. With biochemical thyrotoxicosis, positive TRAb/TSI strongly supports Graves. Diffuse increased uptake or increased Doppler vascularity can help establish the cause when needed. A scan and antibody testing answer overlapping questions; neither is categorically the only valid diagnostic approach. [4]
A diffuse smooth goiter, thyroid bruit, and orbitopathy favor Graves. Lid retraction and lid lag can accompany thyrotoxicosis generally. Proptosis with orbital inflammation is much more specific for thyroid eye disease, but it can occur with normal thyroid function or, rarely, autoimmune hypothyroidism. Orbital and pretibial fibroblast activation promotes glycosaminoglycan accumulation. Pretibial myxedema is a localized dermopathy, distinct from generalized hypothyroid myxedema. New reduced acuity, impaired color vision, corneal exposure, or severe eye pain warrants urgent eye assessment. Smoking cessation matters for orbitopathy. [2]
A single focus of increased uptake with suppression of surrounding tissue suggests a toxic adenoma. Multiple irregular foci suggest toxic multinodular goiter, often after years of nodular enlargement. Neither requires TRAb. Iodine exposure can precipitate excess synthesis in autonomous tissue. [4]
Subacute de Quervain thyroiditis usually has a painful tender gland, recent respiratory illness, increased inflammatory markers, and transient hormone leakage. NSAIDs treat pain; glucocorticoids may be needed for substantial or persistent inflammation. Painless and postpartum thyroiditis are autoimmune destructive processes. A thyrotoxic phase can be followed by hypothyroidism and recovery, but not everyone experiences all phases or recovers permanently. Beta blockade may relieve palpitations; methimazole does not stop leakage of stored hormone. Marked focal pain, systemic toxicity, or an abscess instead requires evaluation for suppurative thyroiditis. [6]
Low uptake with low thyroglobulin suggests exogenous hormone, whereas destructive thyroiditis often increases thyroglobulin. Interpret thyroglobulin with its antibodies because they can interfere with measurement. Discuss prescriptions and supplements neutrally; an external source does not establish intent. [4]
Choose replacement or suppression
When thyroid output is insufficient
Hashimoto thyroiditis involves immune-mediated follicular injury, including cellular immunity. Anti-TPO and anti-thyroglobulin are markers, not a complete explanation of tissue destruction. Classic histology shows lymphocytic infiltration, germinal centers, and oncocytic Hürthle-cell change. [17] A firm painless goiter may eventually become atrophic. Early destructive thyrotoxicosis, called hashitoxicosis, does not make this Graves disease. Iodine deficiency, thyroidectomy, radioiodine, and medications are other causes of hypothyroidism. Dietary and geographic context help identify iodine deficiency without assuming every patient in a country has adequate intake. [3][6]
Levothyroxine is standard replacement. In a healthy younger adult with little residual function, a full replacement estimate is roughly 1.6 micrograms/kg/day, adjusted for body composition and clinical context. Coronary disease and frailty favor a lower starting dose and gradual titration. Recheck TSH about 4 to 6 weeks after dose changes, using an individualized reference-range goal rather than forcing everyone to 0.5 to 2.5 mIU/L. Central disease is monitored with free T4, not TSH alone. Confirm or cover possible cortisol deficiency before starting thyroid replacement. [3]
Take levothyroxine consistently on an empty stomach or at a suitable bedtime interval after food. Separate calcium and iron by about four hours. Consider antacids, bile-acid sequestrants, proton-pump inhibitors, soy, malabsorption, and a change of formulation when TSH rises. Liothyronine alone produces less stable exposure and is not routine replacement. Mild isolated TSH increases merit repeat testing before a permanent prescription; persistent marked increases, symptoms, age, cardiovascular risk, and antibodies affect the decision in nonpregnant adults. NICE bases treatment discussions on confirmed persistence, generally on two tests three months apart. Pregnancy uses separate guidance. [16][8][7][3]
When synthesis is excessive
Methimazole inhibits thyroid peroxidase-mediated organification and coupling. PTU also reduces peripheral T4-to-T3 conversion. Methimazole is generally preferred outside early pregnancy and selected emergency contexts. Obtain baseline blood count and liver tests. Fever or sore throat during thionamide therapy requires stopping the drug pending urgent neutrophil assessment. Confirmed agranulocytosis precludes routine switching to the other thionamide because of cross-reaction risk. Jaundice, dark urine, or pruritus requires hepatic assessment. [4]
Radioiodine and surgery are definitive options chosen with gland size, nodules, orbitopathy, reproductive plans, and preference. Radioiodine commonly leads to hypothyroidism requiring replacement and can worsen orbitopathy. Surgery offers prompt control for compressive goiter or concerning nodules. Normal thyroid function and low TRAb after 12 to 18 months of methimazole permit a monitored withdrawal trial; relapse remains possible, and selected patients may continue low-dose therapy after discussion. [4]
Pregnancy and medications change the interpretation
Early gestational hCG can stimulate the TSH receptor. Use pregnancy-appropriate laboratory ranges. Gestational transient thyrotoxicosis, often with hyperemesis and without TRAb, usually receives supportive care rather than antithyroid treatment. Graves requiring medication in early pregnancy generally favors PTU. Use the lowest effective dose and avoid fetal hypothyroidism. The 2026 ATA guideline does not designate a universally preferred thionamide after 16 weeks, so continuing PTU versus changing to methimazole requires individualized discussion and close monitoring. Radioiodine treatment is contraindicated during pregnancy. TRAb can cross the placenta even after maternal thyroid ablation. [8]
Patients taking levothyroxine commonly need a dose increase during pregnancy and prompt laboratory follow-up. A newborn with confirmed congenital hypothyroidism needs timely levothyroxine to protect neurodevelopment; an imaging study must not delay treatment. Newborn screening and congenital disease belong to infancy, not a mislabeled older-child vignette. [7][9]
Amiodarone has more than one pathway
Type 1 is iodine-fueled synthesis, often in nodular tissue or latent Graves. Increased Doppler blood flow supports it; thionamides address synthesis. Type 2 is destructive thyroiditis, often without prior gland disease or increased vascularity. The ETA recommends glucocorticoids for moderate-to-severe disease; milder presentations require individualized assessment of cardiac risk and thyroid severity. Mixed forms occur. In iodine-replete settings uptake may be low in either type, so uptake alone cannot classify the illness. Stopping amiodarone requires a joint cardiac and endocrine decision. It can also cause hypothyroidism. [5]
Lithium can inhibit thyroid-hormone release. Phenytoin and other enzyme-inducing medications can alter hormone metabolism and replacement requirements, with protein-binding and assay effects also possible. Biotin can distort some thyroid assays into an apparent hyperthyroid pattern. An unexpected result without matching symptoms deserves a medication and assay review. [7][1]
Try it here · Checkpoint 2 of 3
Make your prediction before reading the choices. A first attempt is just a starting point.
Case 18
Show answer and explanations for case 18
A. A pituitary TSH-secreting tumor. (Why this does not fit)
TSH is suppressed in amiodarone-induced thyrotoxicosis; a TSH-driven disorder would have inappropriate measurable TSH.
B. Destructive thyroiditis established solely by the low uptake result (Why this does not fit)
Low uptake cannot reliably distinguish the types during iodine loading in an iodine-replete population.
C. Exogenous thyroid hormone as the most likely sole source (Why this does not fit)
An external source ordinarily suppresses gland activity; increased vascularity in a nodular gland during iodine exposure supports synthesis-driven disease.
D. Iodine-driven synthesis in type 1 amiodarone thyrotoxicosis (Best answer)
A nodular substrate and increased flow support active synthesis; the iodine load can suppress uptake in both types.
Takeaway: Use the gland substrate, Doppler findings, antibodies, and course together; low uptake alone is insufficient during amiodarone exposure.
Recognize organ failure before waiting for a hormone number
Thyroid storm
Thyrotoxicosis with fever, central nervous system dysfunction, severe tachycardia or arrhythmia, heart failure, and gastrointestinal or hepatic dysfunction suggests storm. No fixed hormone concentration, temperature, or pulse cutoff is mandatory. Infection, interrupted treatment, and surgery can precipitate it.
Use intensive monitoring, supportive care, trigger treatment, a thionamide, glucocorticoid, and carefully selected beta blockade. In the ATA regimen, administer iodine at least one hour after the thionamide. PTU has a conversion-blocking advantage, but methimazole is also used in storm; a choice containing methimazole is not automatically wrong. Beta blockade can worsen low-output failure or shock, so assess hemodynamics and titrate under close supervision. [4]
Myxedema coma
Severe hypothyroidism with reduced consciousness, hypothermia, hypoventilation, bradycardia, hypotension, or hyponatremia is a clinical emergency. The patient need not be comatose. Support ventilation, glucose, and circulation; identify infection or another trigger.
Give stress-dose IV hydrocortisone before thyroid hormone while adrenal status is uncertain, then IV levothyroxine using age and cardiac risk to guide dosing. Selected patients receive carefully dosed T3. Use passive warming with blankets; active peripheral warming can precipitate vasodilation and cardiovascular collapse. Routine hypothermia advice cannot simply be transplanted into myxedema management. [3][10]
A nodule is a structural question
Measure TSH and evaluate the thyroid and cervical nodes with ultrasound. Suppressed TSH usually prompts scintigraphy to assess autonomy when permissible. A concordant hyperfunctioning nodule generally does not need FNA. Otherwise, ultrasound risk and size guide biopsy. A solid hypoechoic 1.5 cm nodule with irregular margins, punctate echogenic foci, and taller-than-wide shape merits FNA. Normal TSH does not exclude cancer, and a cold nodule is not automatically malignant. [11]
Papillary carcinoma has characteristic nuclear clearing, grooves, and inclusions, sometimes with psammoma bodies. Follicular carcinoma requires capsular or vascular invasion, which cytology alone cannot establish. [18] Medullary carcinoma arises from C cells, often with calcitonin-associated amyloid; calcitonin and CEA assist surveillance. Germline RET-associated MEN2 requires pheochromocytoma assessment before thyroid surgery. MEN2A includes hyperparathyroidism, whereas MEN2B features mucosal neuromas and a marfanoid habitus. These differ from MEN1's pituitary, pancreatic, and parathyroid tumors. [11][12]
A rapidly enlarging invasive mass requires airway and tissue assessment. Anaplastic carcinoma shows malignant undifferentiated cells; lymphoma shows a lymphoid malignancy and is associated with Hashimoto. Riedel thyroiditis can create a hard infiltrative fibrotic gland with extension beyond its capsule, sometimes within IgG4-related disease. It can mimic cancer, and negative anti-TPO is not a required diagnostic criterion. After thyroid surgery, tingling and carpopedal spasm warrant calcium, magnesium, and PTH assessment for parathyroid injury. [13][14][15]
Pair TSH with free T4. For excess hormone, distinguish synthesis from leakage and ingestion. For deficiency, replace hormone with attention to cortisol and drug interactions. For decompensation, treat immediately. For a nodule, answer the structural question with ultrasound-based risk assessment.
Try it here · Checkpoint 3 of 3
Make your prediction before reading the choices. A first attempt is just a starting point.
Case 31
Show answer and explanations for case 31
A. Anaplastic thyroid carcinoma needing urgent airway and multidisciplinary review (Best answer)
Rapid local invasion plus undifferentiated malignant histology fits anaplastic carcinoma.
B. Primary thyroid lymphoma with a rapidly enlarging mass threatening the airway (Why this does not fit)
Lymphoma can enlarge rapidly and threaten the airway, especially with autoimmune thyroiditis, but it shows a lymphoid malignant population rather than the described undifferentiated carcinoma cells.
C. Riedel thyroiditis with an infiltrative fibrotic mass causing airway compression (Why this does not fit)
Riedel disease can cause a hard invasive-appearing mass through fibrosis, but the described undifferentiated malignant cells indicate a neoplasm rather than fibrosis alone.
D. Follicular thyroid carcinoma with invasive growth causing local compression (Why this does not fit)
Follicular carcinoma retains follicular differentiation and is diagnosed through capsular or vascular invasion. The undifferentiated pleomorphic histology points instead to anaplastic carcinoma.
Takeaway: A rapidly enlarging thyroid mass needs urgent tissue and airway assessment; hardness alone cannot distinguish fibrosis, lymphoma, and carcinoma.
A. Treat symptoms if needed and monitor for a subsequent hypothyroid phase (Best answer)
The timing and destructive pattern favor postpartum thyroiditis; some patients later need temporary or persistent replacement.
B. Begin methimazole to stop stored-hormone leakage (Why this does not fit)
Thionamides inhibit new synthesis and do not treat the destructive source described.
C. Assume permanent Graves disease solely because she is postpartum (Why this does not fit)
Graves can occur postpartum, but the negative receptor antibodies and low vascularity favor thyroiditis here.
D. Arrange radioiodine ablation after temporary interruption of breastfeeding. (Why this does not fit)
The evidence favors a destructive process that often evolves or resolves; ablation does not address the cause, and radioiodine is unsuitable during breastfeeding.
Takeaway: Postpartum thyroiditis requires follow-up across changing hormone phases.
A. Use liothyronine alone to create a larger immediate hormone effect (Why this does not fit)
T3 peaks can provoke cardiac symptoms and are not routine replacement.
B. Start a low oral levothyroxine dose and titrate with clinical and TSH follow-up (Best answer)
Coronary disease warrants gradual replacement to limit ischemic stress.
C. Observe without replacement and recheck after six months. (Why this does not fit)
Symptomatic overt hypothyroidism needs treatment. Coronary disease changes the starting dose and titration, rather than justifying prolonged non-treatment.
D. Give an IV thyroid-hormone loading dose for myxedema coma (Why this does not fit)
He has overt hypothyroidism but no decompensation supporting emergency loading.
Takeaway: Stable hypothyroidism with coronary disease calls for cautious titration.
A. Perform thyroid ultrasound solely because TSH is abnormal (Why this does not fit)
No structural abnormality is described; ultrasound does not confirm persistent subclinical dysfunction.
B. Commit to lifelong levothyroxine immediately (Why this does not fit)
This single mildly abnormal result does not establish a persistent replacement requirement.
C. Order an uptake scan (Why this does not fit)
Uptake is used for selected thyrotoxic or nodule questions, not this biochemical pattern.
D. Repeat TSH and free T4 in about 3 months for persistence (Best answer)
A single mild TSH elevation with normal free T4 after illness may be transient. NICE bases adult treatment discussions on persistent results, generally two measurements three months apart, together with symptoms and other evidence of thyroid disease. This asymptomatic nonpregnant patient does not need immediate lifelong treatment.
Takeaway: Subclinical describes the laboratory pattern, not an automatic treatment decision.
A. Withdraw medication on the basis of gestational age alone. (Why this does not fit)
Some patients can discontinue under selected conditions, but ongoing treatment decisions require disease assessment; gestational age alone is insufficient.
B. Everyone must switch at exactly 13 weeks (Why this does not fit)
This rigid cutoff and mandatory switch are not the 2026 recommendation.
C. Continue PTU without further liver-risk counseling because the current tests are normal. (Why this does not fit)
Normal current tests do not eliminate later hepatotoxicity. Individualized treatment includes continued safety counseling and appropriate monitoring.
D. Individualize therapy after 16 weeks; evidence establishes no preferred drug (Best answer)
The guideline weighs adverse effects and the risk of loss of control during switching rather than mandating one approach.
Takeaway: Do not turn uncertain comparative evidence into an absolute pregnancy rule.
A. Defer warming measures until the thyroid-hormone level normalizes. (Why this does not fit)
Passive warming and supportive care begin with endocrine treatment; waiting for biochemical recovery leaves hypothermia unaddressed.
B. Use vigorous external heating of the limbs as the default approach (Why this does not fit)
Rapid peripheral vasodilation can worsen hypotension in myxedema coma.
C. Use passive blankets; monitor core temperature and circulation (Best answer)
Passive warming avoids abrupt peripheral vasodilation that can worsen hypotension.
D. Use a forced-air warming blanket to rapidly normalize skin temperature. (Why this does not fit)
Routine vigorous external warming can produce vasodilation and worsen hypotension; the cited consensus favors passive blankets with core and circulatory monitoring.
Takeaway: Avoid aggressive peripheral rewarming in myxedema coma; restore physiology with monitored supportive and hormonal treatment.
A suppressed TSH makes functional characterization useful; a concordant hyperfunctioning nodule is usually managed differently from a nonfunctioning one.
B. Immediate total thyroidectomy based only on diameter. (Why this does not fit)
Size alone does not establish malignancy or the appropriate extent of treatment.
C. Fine-needle aspiration before determining functional status (Why this does not fit)
Suppressed TSH creates a role for scintigraphy; a concordant hyperfunctioning nodule often does not require biopsy.
D. Serum calcitonin as the sole test of autonomy. (Why this does not fit)
Calcitonin reflects C-cell biology, not follicular hormone synthesis by the nodule.
Takeaway: Start nodule assessment with TSH and ultrasound; suppressed TSH creates a role for scintigraphy.
A. Primary hyperparathyroidism. (Why this does not fit)
Excess PTH ordinarily raises calcium and promotes phosphate excretion; it does not fit this pattern.
B. Hungry bone syndrome after correction of high bone turnover. (Why this does not fit)
Hungry bone can cause postoperative hypocalcemia, including after treatment of severe thyrotoxicosis. It generally draws phosphate into bone as well. The high phosphate and low PTH here favor inadequate parathyroid secretion.
C. Postoperative parathyroid injury with reduced PTH secretion. (Best answer)
Low calcium, high phosphate, and low PTH after neck surgery indicate inadequate parathyroid function.
D. Vitamin D deficiency as proven by the elevated phosphate. (Why this does not fit)
Uncomplicated nutritional vitamin D deficiency usually provokes secondary PTH elevation and renal phosphate loss.
Takeaway: Recognize symptomatic postoperative hypocalcemia promptly and treat it while evaluating PTH and magnesium.
